Angiogenesis
Inhibitor Expanded Studies Initiated in Europe and U.S.
Published in Cancer Weekly, June 29th, 1998
The first of these trials, a Phase I/II study, is conducted by Ian Judson, M.D., Cancer Research Campaign (CRC) Center for Cancer Therapeutics at the Institute for Cancer Research (ICR) and the Royal Marsden Hospital (RMH) in London, United Kingdom.
The study includes up to 24 patients and assesses leakiness of tumor blood vessels as a biological marker for the angiogenic process in addition to monitoring safety and pharmacokinetic parameters for SU5416. Professor Paul Workman, Ph.D.,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-06-29)
More Articles from Cancer Weekly
- Conference Coverage (ASCO)
Alternative Medicine Used to Compliment Conventional Cancer Therapy - Conference Coverage (ASCO)
Adenovirus-Mediated Gene Therapy Tolerated by Brain Tumor Patients - Therapies
Addition of TNP-470/minocycline to Paclitaxel and Carboplatin - Therapies
As and AAs are Not Good Candidates for Anti-Angiogenic Therapy - Biochemical Behavior
Role of Nitric Oxide in Angiogenesis and Tumor Progression - Drug Development (Cancer)
Oral Anti-Angiogenesis Drug AG3340 in Patients with Advanced Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
